The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Self-reported Antiretroviral Therapy in Injection Drug Users
Abstract
CONTEXT: The US Public Health Service and the International AIDS Society-USA recently published recommendations for antiretroviral therapy (ART) for persons infected with human immunodeficiency virus (HIV); however, anecdotal evidence suggests that HIV-infected injection drug users (IDUs) may not be receiving optimal care as defined by the recommendations. OBJECTIVE: To assess ART use in HIV-infected IDUs. DESIGN: A cross-sectional survey of self-reported ART use between July 1996 and June 1997 in IDUs. SETTING: A community-based clinic affiliated with Johns Hopkins University, Baltimore, Md. PARTICIPANTS: A total of 404 HIV-infected IDUs with CD4+ cell counts less than 0.50 x 10(9)/L recruited into a longitudinal study in 1988 and 1989. MAIN OUTCOME MEASURE: Self-reported ART use was assessed: no current therapy, monotherapy, or combination therapy with or without a protease inhibitor. RESULTS: One half (199/404 [49%]) of patients reported no recent ART. A total of 14% (58/404) had monotherapy, 23% (90/404) were receiving combination therapy without a protease inhibitor, and 14% (57/404) had triple-combination therapy with a protease inhibitor. A multivariate analysis of factors associated with ART showed that care continuity and recent HIV-related outpatient visit (odds ratio [OR], 4.30; 95% confidence interval [CI], 2.36-7.81 and OR, 2.84; 95% CI, 1.66-4.88, respectively), CD4+ cell count of less than 0.20 x 10(9) (OR, 2.41; 95% CI, 1.51-3.84), no current drug use and being in drug treatment (OR, 2.16; 95% CI, 1.34-3.47; OR, 2.12; 95% CI, 1.23-3.66, respectively), and unemployment (OR, 2.31; 95% CI, 1.21-4.40) were associated with reporting ART use. In other analysis, less likely to receive protease inhibitors were current drug injectors (OR, 0.5; 95% CI, 0.3-1.0) and those recently incarcerated (OR, 0.2; 95% CI, 0.03-0.9), but patients with acquired immunodeficiency syndrome were more likely to receive protease inhibitors (OR, 2.0; 95% CI, 0.9-4.6). Protease inhibitor use doubled (P<.01) from July and December 1996 to January and June 1997 (7.7% and 14.8%, respectively). CONCLUSIONS: Those IDUs infected with HIV who were not receiving ART tended to be active drug users without clinical disease who have less contact with health care providers. Although we do not have information on clinical judgment regarding treatment decisions or whether persons were prescribed therapy not taken, the proportion of subjects reporting receiving ART suggests that strategies for improving treatment in this population are indicated. Expanding simultaneous treatment services for HIV infection and substance abuse would enhance the response to these related epidemics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Flexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
Carpenter, C. C. J. (1997) · JAMA · doi:10.1001/jama.1997.03540480062040 · Cited by 725
HIV-1 protease inhibitors. A review for clinicians
Deeks, S. G. (1997) · JAMA · doi:10.1001/jama.277.2.145 · Cited by 675
Compliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.7.1509 · Cited by 405
Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community
Moore, R. D., Stanton, D., Gopalan, R., & Chaisson, R. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301107 · Cited by 356
Vlahov, D., US Department of Health and Human Services; National Institute on Drug Abuse, Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., & Polk, B. F. (1991) · PsycEXTRA Dataset · doi:10.1037/e496262006-006 · Cited by 336
Self-citationPotential factors affecting adherence with HIV therapy
Mehta, S., Moore, R. D., & Graham, N. M. H. (1997) · AIDS · doi:10.1097/00002030-199714000-00002 · Cited by 324
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Perspective: Validating Surrogate Markers--Are We Being Naive?
Gruttola, V. D., Fleming, T. R., Lin, D. Y., & Coombs, R. W. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.2.237 · Cited by 130
Cited by
(2002) · PubMed Central · Cited by 522
Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002) · AIDS · doi:10.1097/00002030-200203290-00012 · Cited by 320
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women
Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K., & Schoenbaum, E. E. (2002) · AIDS · doi:10.1097/00002030-200211080-00010 · Cited by 268
The Impact of Mental Health and Substance Abuse Factors on HIV Prevention and Treatment
Walkup, J., Blank, M. B., Gonzalez, J. S., Safren, S., Schwartz, R., Brown, L., Wilson, I., Knowlton, A., Lombard, F., Grossman, C., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181605b26 · Cited by 150
Impact of HIV Infection on Mortality in a Cohort of Injection Drug Users
Tyndall, M. W., Craib, K. J. P., Currie, S., Li, K., O'Shaughnessy, M. V., & Schechter, M. T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200112010-00008 · Cited by 135
Metadata
- Authors
- Celentano, D. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-08-12
- Volume
- 280
- Issue
- 6
- Pages
- 544
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2002366665
- Cited by
- 258
- References
- 14
- FWCI
- 20.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Self-reported Antiretroviral Therapy in Injection Drug Users. https://app.cochat.ai/papers/10.1001/jama.280.6.544
- The paper
- Celentano, D. D. (1998). Self-reported Antiretroviral Therapy in Injection Drug Users. JAMA. https://doi.org/10.1001/jama.280.6.544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.